Goldline Pharmaceutical SME IPO Subscribed over 750 Times on Final Day, GMP over 35%
The Goldline Pharmaceutical IPO is heading for one of the most heavily subscribed SME issues of the month, with the Rs 1... Read More →
Stay updated with the latest market insights, IPO analysis, and investment guides.
The Goldline Pharmaceutical IPO is heading for one of the most heavily subscribed SME issues of the month, with the Rs 1... Read More →
Bagmane Prime Office REIT made its stock market debut on Thursday at Rs 103.50 per unit on the NSE, a 3.5% premium over... Read More →
Reliance Industries has handed its eldest son the keys to Jio Platforms. Akash Ambani is now the Managing Director of th... Read More →
Another retail player is knocking on Dalal Street's door. Gaurik Fashions Limited, the New Delhi-based company that runs... Read More →
OYO is finally getting through the door. PRISM, the parent company of OYO, is set to receive its final SEBI nod for the... Read More →
Mukesh Ambani has made up his mind. Jio Platforms will go public — but on his terms, not those of the global inves... Read More →
The market regulator SEBI has approved six companies to launch their upcoming Mainboard IPOs, and the big news is that Z... Read More →
InCred Holdings Limited has filed its Updated Draft Red Herring Prospectus (UDRHP) with SEBI for an IPO with total deal... Read More →
The much-talked-about Recode Studios IPO is closing today on the BSE SME platform, and the response from investors has b... Read More →